Glucosylceramide Administration as a Vaccination Strategy in Mouse Models of Cryptococcosis

Role of Sterylglucosidase 1 (Sgl1) on the pathogenicity of Cryptococcus neoformans: potential applications for vaccine development

(2015) Antonella Rella et al.   Frontiers in Microbiology

Vaccine-Mediated Immune Responses to Experimental Pulmonary Cryptococcus gattii Infection in Mice

(2014) Ashok K. Chaturvedi et al.   PLoS One

Synthesis and Biological Properties of Fungal Glucosylceramide

(2014) Maurizio Del Poeta et al.   PLoS Pathogens

Structural Determination of Glucosylceramides in the Distillation Remnants of Shochu, the Japanese Traditional Liquor, and Its Production by Aspergillus kawachii

(2012) Miyo Hirata et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Beta-Glucosylceramide Administration (i.p.) Activates Natural Killer T cells In Vivo and Prevents Tumor Metastasis in Mice

(2012) Masashi Inafuku et al.   LIPIDS

Methylation of glycosylated sphingolipid modulates membrane lipid topography and pathogenicity of Cryptococcus neoformans

(2011) Arpita Singh et al.   CELLULAR MICROBIOLOGY

Surface Localization of Glucosylceramide during Cryptococcus neoformans Infection Allows Targeting as a Potential Antifungal

(2011) Ryan Rhome et al.   PLoS One

Evaluation of Cryptococcus neoformans galactoxylomannan–protein conjugate as vaccine candidate against murine cryptococcosis

(2011) Siu-Kei Chow et al.   VACCINE

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

(2009) Benjamin J Park et al.   AIDS

Insights into the Mechanisms of Protective Immunity against Cryptococcus neoformans Infection Using a Mouse Model of Pulmonary Cryptococcosis

(2009) Karen L. Wozniak et al.   PLoS One

Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine

(2009) Sarah A. Kopecky-Bromberg et al.   VACCINE

Therapeutic Efficacy of a Conjugate Vaccine Containing a Peptide Mimotope of Cryptococcal Capsular Polysaccharide Glucuronoxylomannan

(2008) K. Datta et al.   Clinical and Vaccine Immunology

Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, α-galactosylceramide

(2008) Yaoxing Huang et al.   VACCINE